The time window of MRI of murine atherosclerotic plaques after administration of CB2 receptor targeted micelles: Inter-scan variability and relation between plaque signal intensity increase and gadolinium content of inversion recovery prepared versus non-prepared fast spin echo

NMR in Biomedicine

Volumn 23, Issue 8, 2010, Pages 939-951

  Te Boekhorst, B C M ^a,b   Bovens, S M ^b   Van De Kolk, C W A ^a   Cramer, M J M ^a   Doevendans, P A F M ^a   Ten Hove, M ^a   Van Der Weerd, L ^c   Poelmann, R ^c   Strijkers, G J ^d   Pasterkamp, G ^a   Van Echteld, C J A ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Atherosclerosis; Contrast agents; Inversion recovery fast spin echo; Molecular MRI

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTRAST AGENT; CONTRAST-ENHANCED; CONTROL GROUPS; ENHANCEMENT RATIOS; FAST SPIN ECHOS; INTRAVENOUS INJECTIONS; INVERSION RECOVERY; MOLECULAR MRI; SIGNAL INTENSITIES; SPIN ECHO; TIME FRAME; TIME WINDOWS;

DISEASES; ELECTROMAGNETIC INDUCTION; GADOLINIUM; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; MICELLES; RECOVERY;

SPIN POLARIZATION;

CANNABINOID 2 RECEPTOR; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; MACROPHAGE; MALE; MASS SPECTROMETRY; MICELLE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS;

ANIMALS; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; MICELLES; NITRIC OXIDE SYNTHASE TYPE III; PLAQUE, ATHEROSCLEROTIC; RECEPTOR, CANNABINOID, CB2; TIME FACTORS; TISSUE DISTRIBUTION;

MURINAE; MUS;

EID: 78651478015     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1514     Document Type: Article

References (29)

1. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl. Acad. Sci. USA. 2007; 104: 961-966.
2. Lipinski MJ, Amirbekian V, Frias JC, Aguinaldo JG, Mani V, Briley-Saebo KC, Fuster V, Fallon JT, Fisher EA, Fayad ZA. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn. Reson. Med. 2006; 56: 601-610.
3. Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, Rousseaux O, Le GS, Port M, Lijnen HR, Bruneval P, Michel JB, Ouimet T, Roques B, Amirbekian S, Hyafil F, Vucic E, Aguinaldo JG, Corot C, Fayad ZA. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler. Thromb Vasc. Biol. 2008; 28: 425-432.
4. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA, Fayad ZA. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small. 2008; 4: 1437-1444.
5. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E, Amirbekian V, Tang C, Chin PT, Nicolay K, Fayad ZA. Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn. Reson. Med. 2007; 58: 1164-1170.
6. Briley-Saebo KC, Amirbekian V, Mani V, Aguinaldo JG, Vucic E, Carpenter D, Amirbekian S, Fayad ZA. Gadolinium mixed-micelles: effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis. Magn. Reson. Med. 2006; 56: 1336-1346.
7. Cornily JC, Hyafil F, Calcagno C, Briley-Saebo KC, Tunstead J, Aguinaldo JG, Mani V, Lorusso V, Cavagna FM, Fayad ZA. Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J. Magn. Reson. Imaging. 2008; 27: 1406-1411.
8. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 2003; 108: 2270-2274.
9. Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano. Lett. 2006; 6: 2220-2224.
10. Lobbes MB, Miserus RJ, Heeneman S, Passos VL, Mutsaers PH, Debernardi N, Misselwitz B, Post M, Daemen MJ, van Engelshoven JM, Leiner T, Kooi ME. Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine. Radiology. 2009; 250: 682-691.
11. Chen W, Vucic E, Leupold E, Mulder WJ, Cormode DP, Briley-Saebo KC, Barazza A, Fisher EA, Dathe M, Fayad ZA. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast. Media. Mol. Imaging. 2008; 3: 233-242.
12. Zheng J, Ochoa E, Misselwitz B, Yang D, El Naga I, Woodard PK, Abendschein D. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits. Invest Radiol. 2008; 43: 49-55.
13. Kawahara I, Morikawa M, Honda M, Kitagawa N, Tsutsumi K, Nagata I, Hayashi T, Koji T. High-resolution magnetic resonance imaging using gadolinium-based contrast agent for atherosclerotic carotid plaque. Surg. Neurol. 2007; 68: 60-65.
14. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, Weinmann HJ, Fuster V, Toussaint JF, Fayad ZA. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation. 2004; 109: 2890-2896.
15. Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation. 2003; 108: 605-609.
16. Neubauer AM, Sim H, Winter PM, Caruthers SD, Williams TA, Robertson JD, Sept D, Lanza GM, Wickline SA. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging. Magn. Reson. Med. 2008; 60: 1353-1361.
17. Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008; 117: 3206-3215.
18. Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard JL, Mach F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature. 2005; 434: 782-786.
19. Mach F, Steffens S. The role of the endocannabinoid system in atherosclerosis. J Neuroendocrinol. 2008; 20 (Suppl 1): 53-57.
20. Te Boekhorst BC, Rodriguez-Feo J, Bovens SM, De Kroon TI, Cramer MJ, Pasterkamp G, Doevendans PA, Van Echteld CJ. Characterization of micelle-based contrast agent targeting peripheral cannabis receptors and its potential use for atherosclerotic plaque visualization by MRI. 9(2): 256-257.
21. Mitchell DG. Preparatory Pulses, Including Fat Suppression. MRI Principles. Saunders: Philadelphia, PA, 2004; 177-198.
22. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001; 104: 448-454.
23. Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. USA. 1999; 96: 14228-14233.
24. Kwee TC, Takahara T, Ochiai R, Katahira K, Van Cauteren M, Imai Y, Nievelstein RA, Luijten PR. Whole-body diffusion-weighted magnetic resonance imaging. Eur. J. Radiol. 2009; 70: 409-417.
25. Terreno E, Geninatti CS, Belfiore S, Biancone L, Cabella C, Esposito G, Manazza AD, Aime S. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn. Reson. Med. 2006; 55: 491-497.
26. Strijkers GJ, Hak S, Kok MB, Springer CS Jr, Nicolay K. Three-compartment T1 relaxation model for intracellular paramagnetic contrast agents. Magn. Reson. Med. 2009; 61: 1049-1058.
27. Kok MB, Hak S, Mulder WJ, van der Schaft DW, Strijkers GJ, Nicolay K. Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1 and T2 relaxivity. Magn. Reson. Med. 2009; 61: 1022-1032.
28. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003; 17: 545-580.
29. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006; 19: 142-164.